Removal and Absorption of Antibiotics in Patients with Renal Failure Undergoing Peritoneal Dialysis
- 1 March 1967
- journal article
- research article
- Published by American College of Physicians in Annals of Internal Medicine
- Vol. 66 (3) , 465-479
- https://doi.org/10.7326/0003-4819-66-3-465
Abstract
Tetracycline, chloramphenicol, kanamycin and colistimethate were administered to 24 uremic patients undergoing peritoneal dialysis. Of these 4 antibiotics, only kanamycin is removed by peritoneal dialysis in amounts significant enough to dictate major change of the presently accepted dosage schedule. Colistimethate warrants some minor dosage adjustment, although it is less effectively removed than kanamycin. Peritoneal dialysis is ineffective in removing significant amounts of either tetracycline or chloramphenicol. When administered intraperitoneally, both tetracycline and chloramphenicol are rapidly absorbed. This has more significance for tetracycline since the serum half-life of active chloramphenicol does not appear to be significantly altered by renal failure. In contrast, tetracycline half-life is greatly prolonged and toxic serum levels may be rapidly attained and maintained unless a reduced dosage schedule is adopted. Kanamycin and colistimethate were both absorbed when administered intraperitoneally, but in the doses used in this study, not effectively enough to produce therapeutic blood levels.Keywords
This publication has 21 references indexed in Scilit:
- KANAMYCIN: PHARMACOLOGICAL, MICROBIOLOGICAL, AND CLINICAL OBSERVATIONS*Annals of the New York Academy of Sciences, 2006
- Respiratory and Cardiac Arrest After Intravenous Administration of Kanamycin with Reversal of Toxic Effects by NeostigmineAnnals of Internal Medicine, 1963
- Renal Disease and the Metabolic Effects of TetracyclineAnnals of Internal Medicine, 1963
- The Treatment of Gram-negative Bacillary Infections with ColistinAnnals of Internal Medicine, 1962
- KANAMYCIN .2. OTOTOXICITYPublished by Elsevier ,1960
- PERSISTENCE OF ANTIBIOTICS IN BLOOD OF PATIENTS WITH ACUTE RENAL FAILURE. II. CHLORAMPHENICOL AND ITS METABOLIC PRODUCTS IN THE BLOOD OF PATIENTS WITH SEVERE RENAL DISEASE OR HEPATIC CIRRHOSIS*†Journal of Clinical Investigation, 1959
- PERSISTENCE OF ANTIBIOTICS IN BLOOD OF PATIENTS WITH ACUTE RENAL FAILURE. I. TETRACYCLINE AND CHLORTETRACYCLINE*†Journal of Clinical Investigation, 1959
- PERSISTENCE OF ANTIBIOTICS IN BLOOD OF PATIENTS WITH ACUTE RENAL FAILURE. III. PENICILLIN, STREPTOMYCIN, ERYTHROMYCIN AND KANAMYCIN*†Journal of Clinical Investigation, 1959
- CLINICAL EXPERIENCES WITH KANAMYCIN*Annals of the New York Academy of Sciences, 1958
- BIOCHEMICAL STUDIES ON CHLORAMPHENICOL (CHLOROMYCETIN) .2. TISSUE DISTRIBUTION AND EXCRETION STUDIES1949